Ironwood醫藥 IRWD 深 滬
已收盤 05-08 16:00:00 美东时间
4.22
+0.050
+1.20%
華盛通- 最 高4.38
- 今 開4.26
- 成交量 255.28万股
- 最 低 4.005
- 昨 收 4.17
- 總市值 6.95亿
- 52周最高 5.78
- 市盈率 靜 28.63
- 換手率 1.55%
- 52周最低 0.55
- 委 比 66.51%
- 總股本 1.65亿
- 歷史最高 18.915
- 量 比 0.72
- 振 幅 8.99%
- 歷史最低 0.5271
- 每 手 1
- 風險率 1.50%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Ironwood Pharmaceuticals Affirms FY2026 Sales Guidance of $450.000M-$475.000M vs $458.593M Est
Ironwood Pharmaceuticals (NASDAQ:IRWD) affirms FY2026 sales outlook from $450.000 million-$475.000 million to $450.000 million-$475.000 million vs $458.593 million estimate.
05-07 19:08
Ironwood Pharmaceuticals Q1 Adj. EPS $0.24, Inline, Sales $106.506M Beat $92.088M Estimate
Ironwood Pharmaceuticals (NASDAQ:IRWD) reported quarterly earnings of $0.24 per share which met the analyst consensus estimate. This is a 271.43 percent increase over losses of $(0.14) per share from the same period last
05-07 19:07
Ironwood Pharmaceuticals Presents New Findings From Survey Assessing Healthcare Provider Perspectives On The Use Of Total Parenteral Nutrition In The Treatment Of Short Bowel Syndrome
Surveyed HCPs emphasized the importance of reducing patient dependence on TPN to improve quality of life, reduce line infections and lower the risk of thrombosis. The majority (46.4%) identified reducing the number
05-04 19:16
Avanos Medical, Travere Therapeutics, Globalstar And Other Big Stocks Moving Higher On Tuesday
Dow Jones up 200 points, Avanos Medical Inc rose on going-private deal. Big gainers include AVNS, TVTX, BE, IONQ, SANA, RGTI, VACH, AOSL.
04-14 22:16
新浪财经ESG：Ironwood医药 MSCI（明晟）ESG评级调降至B
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
03-24 10:23
Organon leads ultra-low P/E stocks at 1.8x as small-cap stocks face volatility
Small-cap outperformance has narrowed over the last couple of weeks as investor caution increased, with volatility and geopolitical risk weighing on risk appetite and narrowing the performance gap vs....
03-19 01:25
Ironwood Pharmaceuticals director Alexander J. Denner disposes of shares worth USD 20.53 million
Ironwood Pharmaceuticals director Alexander J. Denner disposes of shares worth USD 20.53 million Alexander Denner, a director, reported a disposal of 6.73 million common shares of Ironwood Pharmaceuticals at USD 3.05 per share. Disclaimer: This news brief was created by Public Technologies (PUBT) us
03-18 08:35
Small-Cap healthcare stocks ranked by quant ratings after earnings season
As earnings season winds down, investors are shifting focus to updated quant ratings following the latest wave of corporate results. The scores offer a snapshot of how companies rank across key factor...
03-13 21:55
BRIEF-Ironwood Pharmaceuticals Satisfies Liquidity Conditions In Credit Agreement On March 10
BRIEF-Ironwood Pharmaceuticals Satisfies Liquidity Conditions In Credit Agreement On March 10 March 11 (Reuters) - Ironwood Pharmaceuticals Inc IRWD.O : IRONWOOD PHARMACEUTICALS INC - SATISFIES LIQUIDITY CONDITIONS IN CREDIT AGREEMENT ON MARCH 10, 2026 - SEC FILING IRONWOOD PHARMACEUTICALS INC - MAT
03-11 19:18
美股大行评级 | 最高300美元！大摩、小摩、花旗纷纷上调英伟达目标价；赛富时、C3.ai、Snowflake、Trade Desk等遭数十家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持NovoCure"买入"评级，目标价从47美元升至49美元；Citizens：维持Ironwood医药"跑赢大市"评级，目标价从8美元升至10美元
02-27 11:07
